SCHEMBL252393

SCHEMBL252393

CNc1nc2ncccc2cc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.47
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
KDM4E B2RXH2 3/20 0.47
GAA P10253 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
ALDH1A1 P00352 5/20 0.42
DHODH Q02127 2/20 0.42
MAPT P10636 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
CYP3A4 P08684 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
BLM P54132 1/20 0.41
AGER Q15109 1/20 0.41
NAPRT Q6XQN6 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9378964 0.87 PARP1 (0.46) LMNAMEN1KMT2AKDM4EGAA
SCHEMBL7536305 0.82 PTPN1 (0.50) LMNAMEN1KMT2AKDM4EGAA
SCHEMBL617599 0.81 MAPT (0.49) LMNAKDM4EGAAALDH1A1MAPT
SCHEMBL125290 0.80 LMNA (0.51) LMNAMEN1KMT2AKDM4EGAA
SCHEMBL7278161 0.78 KDM4E (0.55) LMNAMEN1KMT2AKDM4ETDP1
SCHEMBL352470 0.78 KDM4E (0.53) LMNAMEN1KMT2AKDM4ETDP1
SCHEMBL27836545 0.76 LMNA (0.56) LMNAMEN1KMT2AKDM4ETDP1
SCHEMBL28550680 0.76 KDM4E (0.47) LMNAMEN1KMT2AKDM4EGAA
SCHEMBL252332 0.76 ALDH1A1 (0.47) LMNAMEN1KMT2AKDM4ETDP1
SCHEMBL29712338 0.75 DHODH (0.64) LMNAMEN1KMT2AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401275-B1 NAPHTHYRIDINE DERIVATIVES HAVING BRONCHODILATING ACTIVITY RESPIRATORIUS AB (SE) 2013-07-24 EP disclosed
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US disclosed
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2012-02-16 US disclosed
EP-2401275-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS Respiratorius AB (SE) 2012-01-04 EP disclosed
WO-2010097410-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2010-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS CHRM3, ADRB1, ADRB3 LMNA 4429/4885MEN1 3494/4885KMT2A 3409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.